RTIX  Rti Biologics Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Industrial Specialties

Market Cap.

242.5M

Poor Cash Return on Invested Capital over the past 5 years

RTIX has been unable to consistently generate sufficient returns from its investments in buildings, projects and equipment. This could be due to poor management, lack of an economic moat or the capital intensive nature of the business.

RTIX has only created $5.64 of cash for every $100 invested.
Figures in USD. Fiscal year ends in December
20072008200920102011
Free Cash Flow 4.89M -7.45M -8.80M 26.15M 19.28M
divided by
Invested Capital 99.59M 272.48M 299.13M 164.10M 148.23M
Cash ROIC 4.91% -2.73% -2.94% 15.93% 13.01%

Very Poor Return on Equity over the past 5 years

RTIX has shown an inability to deliver results for shareholders. This could be due to poor management, RTIX operating in a highly competitive industry, or having a weak business in general.

RTIX has generated a $22.10 loss for every $100 of Shareholders' Equity.
Figures in USD. Fiscal year ends in December
20072008200920102011
Net Income -2.10M -99.98M 5.86M -129.40M 8.38M
divided by
Stockholders' Equity 111.64M 281.05M 289.89M 161.94M 172.42M
Return on Equity -1.88% -35.57% 2.02% -79.91% 4.86%

Poor Business Performance over the past 10 years

RTIX's inability to produce positive free cash flow for the majority of the past 10 years is concerning. It should be a red flag, since this company does not have a track record of delivering results for shareholders. This could be due to poor management or the nature of its business.

RTIX has been losing money for the majority of the past 10 years.
Figures in USD. Fiscal year ends in December
2002200320042005200620072008200920102011
Free Cash Flow -9.19M -3.58M -5.69M -7.28M -8.07M 4.89M -7.45M -8.80M 26.15M 19.28M